Envista Acquires Osteogenics Biomedical Business
May 17, 2022
Envista Holdings Corporation entered into a definitive agreement to acquire Osteogenics Biomedical, Allotech LLC and OBI Biologics (collectively “Osteogenics”), a developer of regenerative dental bone grafting products sold primarily under the Cytoplast brand. The deal, subject to customary regulatory approvals and expected to close in the third quarter, expands Envista’s capabilities in regenerative solutions for periodontists, oral and maxillofacial surgeons and implant dentistry; the transaction is not subject to a financing condition or shareholder vote.
- Buyers
- Envista Holdings Corporation
- Targets
- Osteogenics Biomedical Inc, Allotech LLC, OBI Biologics, Inc
- Industry
- Medical Devices
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Avista Healthcare Partners Acquires EBI Bone Healing Division from Highridge Medical
June 4, 2025
Medical Devices
Avista Healthcare Partners has acquired EBI, the bone healing division of Highridge Medical, marking Avista's 50th platform healthcare investment. The deal is a carve-out/divestiture from Highridge (a H.I.G. Capital portfolio company) intended to position EBI as a standalone leader in bone growth stimulation technologies.
-
Keensight Capital Acquires Majority Stake in Isto Biologics
September 22, 2025
Medical Devices
Keensight Capital has acquired a majority stake in Isto Biologics, a US-based regenerative MedTech company focused on orthobiologic bone graft solutions. Thompson Street Capital Partners will retain a minority stake alongside Isto's management; Keensight plans to support Isto's international expansion and pursue additional acquisitions to accelerate growth.
-
OmniActive Health Technologies Acquires ENovate Biolife
November 4, 2024
Food & Beverage
OmniActive Health Technologies has acquired ENovate Biolife to expand its portfolio of clinically validated botanical and specialty active ingredients for dietary supplements, functional foods and sports nutrition. The acquisition strengthens OmniActive's R&D, clinical and commercial capabilities and aims to accelerate global distribution of ENovate's ingredients such as Muvz, RedNite and Oxyjun.
-
Avanos Medical Acquires OrthogenRx for $160M
December 13, 2021
Medical Devices
Avanos Medical, Inc. has entered into a definitive agreement to acquire OrthogenRx, Inc. for $160 million ($130M cash at closing plus up to $30M contingent on milestones). The acquisition adds OrthogenRx's FDA-approved viscosupplementation products GenVisc 850 and TriVisc to Avanos' chronic pain portfolio to expand its continuum-of-care offerings for knee osteoarthritis patients.
-
BioIVT Acquires ZenBio
August 21, 2024
Healthcare Services
BioIVT has acquired ZenBio, a Durham-based provider of advanced cell products and biospecimen services, to expand its skin-based expertise, primary cell and exosome isolation capabilities, and blood product offerings for pharmaceutical and cosmetics research. The deal strengthens BioIVT's service portfolio and complements recent integrations to accelerate support for drug discovery and cosmeceutical development; financial terms were not disclosed.
-
IK Partners Acquires Majority Stake in BIOBank
May 29, 2024
Medical Devices
IK Partners (via its IK Small Cap III fund) has agreed to acquire a majority stake in French tissue bank BIOBank from Verto Growth, Capital Croissance and management, who will reinvest. BIOBank, headquartered in Lieusaint, France, is a leading processor and distributor of bone allografts for orthopaedic, spine, dental and cranio‑maxillofacial surgery; IK plans to support market-share gains in France, accelerate international expansion and pursue a buy‑and‑build strategy.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.